SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?


To: Nutbuster who wrote (3674)3/25/1999 8:36:00 PM
From: Jim Johnson  Respond to of 4650
 
I was reading some on the SEC filing stuff today. Two things I didn't care for. First, I see the G&A expenses (where officer salary is lumped) has gone up almost $400,000 a year (Approximately). The second is it plainly says they are going to continue to fund the business by continuing to sell shares into the market. If that is true, the price will be a long time moving anywhere.

Jim J



To: Nutbuster who wrote (3674)3/25/1999 9:31:00 PM
From: Andrew T  Read Replies (2) | Respond to of 4650
 
Hey Nut buster, As far as the "prototype" they could be refering to it as": a first full-scale and functional form of a new type or design of a construction " INSIDER SHARE INFORMATION FROM PREVIOUS FILINGS TO TODAYS FILING LESLIE ROBINS NOW 3,421,546 LAST FILING 1,999,526 * AN ADDITIONAL INCREASE OF 1,422,020 FRANCISCO URREA JR. NOW 400,000 LAST FILING 341,810 *AN ADDITIONAL INCREASE OF 58,190 Grupo Nueve Ltd. NOW 1,199,300 LAST FILING 1,539,300 * A DECREASE OF 340,000 Y. L. Hirsch 1,448,052 Harold Herman 200,000 * HIRSCH AND HERMAN ARE NEW TO THIS RECENT FILING _______________________________________________________________ The company's latest Patent Pending #9247157 relates to an Electro-Optic Light Valve Array. --------------------------------------------------------------- The resignation of Francisco Urrea Jr. as a Director was acknowledged and accepted in November 1998. --------------------------------------------- BioModa is a biomedical development company. The Company's ownership of BioModa, as of December 31, 1998, was 21.93%. The Company holds options to increase this position to 26.4%. ------------------------------------------------------------------